Literature DB >> 3296406

Cicatricial pemphigoid.

C S Foster.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3296406      PMCID: PMC1298749     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  81 in total

1.  PLASTIC EMBEDDING MIXTURES FOR USE IN ELECTRON MICROSCOPY.

Authors:  H H MOLLENHAUER
Journal:  Stain Technol       Date:  1964-03

Review 2.  Ocular surface manifestations of neurological and systemic disease.

Authors:  C S Foster
Journal:  Int Ophthalmol Clin       Date:  1979

3.  Benign mucous membrane pemphigoid. Response to therapy with cyclophosphamide.

Authors:  H J Brody; D J Pirozzi
Journal:  Arch Dermatol       Date:  1977-11

4.  Benign mucous membrane pemphigoid. 3. Biopsy.

Authors:  S R Andersen; O A Jensen; E B Kristensen; M S Norn
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

5.  Factors affecting tear film breakup in normal eyes.

Authors:  M A Lemp; J R Hamill
Journal:  Arch Ophthalmol       Date:  1973-02

6.  Pemphigoid eruptions in the elderly.

Authors:  C C Lim; R H Macdonald; A J Rook
Journal:  Trans St Johns Hosp Dermatol Soc       Date:  1968

7.  Chronic cicatricial conjunctivitis.

Authors:  T H Chalkley
Journal:  Am J Ophthalmol       Date:  1969-04       Impact factor: 5.258

8.  Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient.

Authors:  A M Dvorak; M C Mihm; J E Osage; T H Kwan; K F Austen; B U Wintroub
Journal:  J Invest Dermatol       Date:  1982-02       Impact factor: 8.551

9.  Immunosuppressive therapy for progressive ocular cicatricial pemphigoid.

Authors:  C S Foster; L A Wilson; M B Ekins
Journal:  Ophthalmology       Date:  1982-04       Impact factor: 12.079

Review 10.  Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations.

Authors:  J R Person; R S Rogers
Journal:  Mayo Clin Proc       Date:  1977-01       Impact factor: 7.616

View more
  62 in total

1.  Upper and lower conjunctival fornix depth in healthy white caucasian eyes: a method of objective assessment.

Authors:  G Jutley; D Carpenter; S Hau; D Booth; H A Jasim; E Tay; C Daniel; V Saw
Journal:  Eye (Lond)       Date:  2016-07-08       Impact factor: 3.775

Review 2.  Autoimmune bullous diseases: ocular manifestations and management.

Authors:  Caroline Laforest; Shyamala C Huilgol; Robert Casson; Dinesh Selva; Igal Leibovitch
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Combination treatment of intravenous immunoglobulin and cultivated oral mucosal epithelial transplantation for ocular cicatricial pemphigoid.

Authors:  Y Uchino; S Takahashi; M Uchino; J Shimazaki
Journal:  Br J Ophthalmol       Date:  2007-01       Impact factor: 4.638

4.  Dapsone induced haemolytic anaemia in patients treated for ocular cicatricial pemphigoid.

Authors:  M S Wertheim; J J Males; S D Cook; D M Tole
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

5.  Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid.

Authors:  C S Foster; R Neumann; J Tauber
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

6.  Combination treatment of intravenous immunoglobulin and cultivated oral mucosal epithelial transplantation for ocular cicatricial pemphigoid.

Authors:  Y Uchino; M Uchino; J Shimazaki
Journal:  BMJ Case Rep       Date:  2009-02-02

7.  Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring.

Authors:  Sarah D Ahadome; David J Abraham; Suryanarayana Rayapureddi; Valerie P Saw; Daniel R Saban; Virginia L Calder; Jill T Norman; Markella Ponticos; Julie T Daniels; John K Dart
Journal:  JCI Insight       Date:  2016-08-04

8.  Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid.

Authors:  M J Elder; S Lightman; J K Dart
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

Review 9.  Pharmacotherapy of scleritis: current paradigms and future directions.

Authors:  Robert M Beardsley; Eric B Suhler; James T Rosenbaum; Phoebe Lin
Journal:  Expert Opin Pharmacother       Date:  2013-02-21       Impact factor: 3.889

10.  Cyclophosphamide for ocular inflammatory diseases.

Authors:  Siddharth S Pujari; John H Kempen; Craig W Newcomb; Sapna Gangaputra; Ebenezer Daniel; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; C Stephen Foster
Journal:  Ophthalmology       Date:  2009-12-06       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.